SCHEMBL23336040

SCHEMBL23336040

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3ccc(-c4cc5ccccc5c5ccccc45)c(-c4ccccc4)c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ ATM Q13315 2/20 0.41
▸ CYP11B1 P15538 1/20 0.36
▸ HDAC4 P56524 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ HPGD P15428 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ MPI P34949 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ACP1 P24666 2/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23336202 0.92 KDM4E (0.40) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL23336043 0.91 KDM4E (0.41) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL23336203 0.91 KDM4E (0.46) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL31663570 0.90 L3MBTL1 (0.47) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL23319082 0.90 L3MBTL1 (0.47) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL21191468 0.89 ATM (0.46) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL24780485 0.89 L3MBTL1 (0.42) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL23336041 0.88 CYP11B1 (0.37) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL23336208 0.88 CYP11B1 (0.39) KDM4EL3MBTL1ATMCYP11B1HDAC4
SCHEMBL17943393 0.87 ATM (0.45) KDM4EL3MBTL1ATMCYP11B1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407011-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2022-12-22 — — US disclosed
WO-2021086142-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE 솔브레인 주식회사 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407011-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE OCIAD1, AOX1, OXER1 KDM4E 2841/4885L3MBTL1 116/4885ATM 3966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback